APO Research
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vi Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Typhoid Vi Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025172 pages

Choose your research edition.

Industry ResearchTyphoid Vi Polysaccharide Vaccine Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vi Polysaccharide Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Typhoid Vi Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vi Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vi Polysaccharide Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Typhoid Vi Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Typhoid Vi Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Typhoid Vi Polysaccharide Vaccine include Sanofi Pasteur SA, GSK and Emergent BioSolutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Typhoid Vi Polysaccharide Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Typhoid Vi Polysaccharide Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Typhoid Vi Polysaccharide Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Typhoid Vi Polysaccharide Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Typhoid Vi Polysaccharide Vaccine Segment by Company

Sanofi Pasteur SA

GSK

Emergent BioSolutions

Typhoid Vi Polysaccharide Vaccine Segment by Type

Child

Adult

Typhoid Vi Polysaccharide Vaccine Segment by Application

Government Institution

Private Sector

Other

Typhoid Vi Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vi Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vi Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vi Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Typhoid Vi Polysaccharide Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Typhoid Vi Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Typhoid Vi Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Typhoid Vi Polysaccharide Vaccine Industry Trends Table 2. Typhoid Vi Polysaccharide Vaccine Industry Drivers Table 3. Typhoid Vi Polysaccharide Vaccine Industry Opportunities and Challenges Table 4. Typhoid Vi Polysaccharide Vaccine Industry Restraints Table 5. Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Typhoid Vi Polysaccharide Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers Table 9. Global Typhoid Vi Polysaccharide Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Typhoid Vi Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Typhoid Vi Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Typhoid Vi Polysaccharide Vaccine Manufacturers, Product Type & Application Table 13. Global Typhoid Vi Polysaccharide Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Typhoid Vi Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Child Table 17. Major Manufacturers of Adult Table 18. Global Typhoid Vi Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Institution Table 29. Major Manufacturers of Private Sector Table 30. Major Manufacturers of Other Table 31. Global Typhoid Vi Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 33. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 34. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2021-2026) & (k units) Table 38. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2027-2032) & (k units) Table 39. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Typhoid Vi Polysaccharide Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Typhoid Vi Polysaccharide Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 48. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 49. Europe Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 51. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Typhoid Vi Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 63. Sanofi Pasteur SA Company Information Table 64. Sanofi Pasteur SA Business Overview Table 65. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 67. Sanofi Pasteur SA Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Typhoid Vi Polysaccharide Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 72. GSK Recent Development Table 73. Emergent BioSolutions Company Information Table 74. Emergent BioSolutions Business Overview Table 75. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio Table 77. Emergent BioSolutions Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Typhoid Vi Polysaccharide Vaccine Distributors List Table 81. Typhoid Vi Polysaccharide Vaccine Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Typhoid Vi Polysaccharide Vaccine Product Image Figure 2. Global Typhoid Vi Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vi Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Typhoid Vi Polysaccharide Vaccine Sales (2021-2032) & (k units) Figure 5. Global Typhoid Vi Polysaccharide Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Child Image Figure 9. Adult Image Figure 10. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government Institution Image Figure 17. Private Sector Image Figure 18. Other Image Figure 19. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Typhoid Vi Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Typhoid Vi Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Typhoid Vi Polysaccharide Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Typhoid Vi Polysaccharide Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Child
  • Adult
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Sanofi Pasteur SA
  • GSK
  • Emergent BioSolutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Typhoid Vi Polysaccharide Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Typhoid Vi Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Typhoid Vi Polysaccharide Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Typhoid Vi Polysaccharide Vaccine Market Dynamics
  1. 2.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
  2. 2.2 Typhoid Vi Polysaccharide Vaccine Industry Drivers
  3. 2.3 Typhoid Vi Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vi Polysaccharide Vaccine Industry Restraints
3 Typhoid Vi Polysaccharide Vaccine Market by Manufacturers
  1. 3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Typhoid Vi Polysaccharide Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Typhoid Vi Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Typhoid Vi Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Typhoid Vi Polysaccharide Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Typhoid Vi Polysaccharide Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Typhoid Vi Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Typhoid Vi Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Typhoid Vi Polysaccharide Vaccine Market by Type
  1. 4.1 Typhoid Vi Polysaccharide Vaccine Type Introduction
  2. 4.1.1 Child
  3. 4.1.2 Adult
  4. 4.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Type
  5. 4.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type
  9. 4.3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
5 Typhoid Vi Polysaccharide Vaccine Market by Application
  1. 5.1 Typhoid Vi Polysaccharide Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Application
  6. 5.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application
  10. 5.3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
6 Global Typhoid Vi Polysaccharide Vaccine Sales by Region
  1. 6.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region
  1. 7.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region
  2. 7.1.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur SA
  2. 8.1.1 Sanofi Pasteur SA Company Information
  3. 8.1.2 Sanofi Pasteur SA Business Overview
  4. 8.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio
  6. 8.1.5 Sanofi Pasteur SA Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Emergent BioSolutions
  14. 8.3.1 Emergent BioSolutions Company Information
  15. 8.3.2 Emergent BioSolutions Business Overview
  16. 8.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio
  18. 8.3.5 Emergent BioSolutions Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Typhoid Vi Polysaccharide Vaccine Value Chain Analysis
  2. 9.1.1 Typhoid Vi Polysaccharide Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Typhoid Vi Polysaccharide Vaccine Production Mode & Process
  6. 9.2 Typhoid Vi Polysaccharide Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Typhoid Vi Polysaccharide Vaccine Distributors
  9. 9.2.3 Typhoid Vi Polysaccharide Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst